Crowdsourced medical diagnosis and second opinions

Platform connecting patients with rare or difficult medical conditions to a crowd of medical experts for diagnosis and treatment advice.

YC GraveyardJun 1, 2013TemplateMedicine & HealthSource

FL score

out of 100

Verdict

VALIDATE

high confidence

Competition

competitors found, emerging market, funded players

Trend

No signal yet

A high-pain, high-potential idea for AI-assisted medical research collaboration in rare diseases, but requires extensive validation around trust, legal liability, and solo buildability.

The pain

Patients with rare, undiagnosed, or difficult-to-treat medical conditions face years of misdiagnosis, ineffective treatments, significant suffering, and high costs due to lack of accessible expert knowledge and collaborative research.

The gap

Current solutions are expensive, employer-centric, or not designed for patient-led research collaboration in niche rare disease communities. A whitespace exists for an AI-assisted tool that facilitates case study and treatment research without providing direct medical advice, specifically targeting these underserved groups.

Build angle

Develop an AI-powered medical research and case collaboration tool for rare disease communities. The platform would help patients and their doctors crowdsource case studies and treatment research, use AI to summarize medical literature, identify similar cases, and facilitate expert matching, strictly avoiding direct medical diagnosis or advice.

Strengths

Extremely high pain point for a desperate, specific audience (rare disease patients).
Significant market growth (medical second opinions, digital health).
Clear whitespace with a unique AI-assisted research/collaboration angle that sidesteps direct medical advice liability.
High willingness to pay for solutions that offer hope or clearer paths.
Leverages mature telemedicine infrastructure and advanced AI capabilities.

Risks

High regulatory and liability risks, even with reframing, as observed with CrowdMed's failure.
Building trust and credibility in the medical domain is challenging for a solo builder.
Complexity of ensuring AI accuracy and avoiding hallucinations in medical contexts.
Difficulty in attracting and retaining qualified medical experts for a non-diagnostic, collaborative platform.
Monetization challenges due to healthcare sensitivity and inconsistent reimbursement policies.
Solo buildability for a robust, secure, and legally compliant platform is questionable.

Next steps

Conduct in-depth interviews with rare disease patients, advocacy groups, and relevant medical specialists to validate specific research needs and willingness to participate/pay.
Consult with legal experts specializing in healthcare tech/AI to understand precise regulatory boundaries and liability mitigation strategies.
Develop a low-fidelity prototype focusing on AI summarization of a single case study or medical paper, and test expert/patient feedback on its utility and accuracy.
Explore partnerships with existing rare disease foundations or medical research institutions to gain credibility and initial user base.

Fly Labs Method

Is the pain real, is there a gap, is it the right time, can one person build it.

Problem clarity: 26
Solution gap: 21
Willingness to pay: 21
Buildability: 8

High pain, clear gap for a niche, high willingness to pay, but significant build complexity and regulatory/liability risks for a solo builder, making it a VALIDATE_FIRST despite strong market signals.

Value Equation

Dream outcome and how likely it feels, against the time and effort it costs.

Good market opportunity with high potential outcomes, but significant execution and regulatory challenges.

One-Person Business

Curiosity pull, identity fit, and a path from free value to paid for a solo creator.

Clear pain and audience, but significant complexity and lack of solo creator fit due to medical and legal requirements.

Viral Frameworks

Hook strength, shareability, and how cheaply it can be tested.

Specific audience and strong value, but high assumption risk and complexity for validation and business model.

Builder Lens

Evidence the problem exists, timing, defensibility, and a model that fits on a napkin.

Strong demand from a desperate, specific audience, with a clear need for a better solution, but execution risk for the narrowest wedge.

Why this verdict

The idea addresses an acute, life-altering pain for a specific, desperate audience within a growing market. The solo builder's angle cleverly attempts to navigate past the regulatory and liability pitfalls that plagued previous ventures like CrowdMed by focusing on 'research collaboration' rather than 'diagnosis'. There are strong signals that this audience would pay for effective solutions. However, the inherent complexities of medical data, AI accuracy, expert recruitment, and stringent legal requirements make this a highly challenging endeavor for a solo builder, with significant risks that need extensive validation before committing to a full build. The YC and Koe lenses highlight the challenges for a solo founder in this sensitive space. It's a promising idea if these substantial risks can be adequately de-risked and a clear, minimal, legally safe MVP path identified.

Five lenses, one composite. How scoring works

The angle

This weekend

Conduct in-depth interviews with rare disease patients, advocacy groups, and relevant medical specialists to validate specific research needs and willingness to participate/pay.
Consult with legal experts specializing in healthcare tech/AI to understand precise regulatory boundaries and liability mitigation strategies.
Develop a low-fidelity prototype focusing on AI summarization of a single case study or medical paper, and test expert/patient feedback on its utility and accuracy.
Explore partnerships with existing rare disease foundations or medical research institutions to gain credibility and initial user base.

Who is already there, emerging market

CrowdMedFundedVisit
CrowdMed uses the wisdom of crowds to help solve difficult medical cases online, aiming to reduce healthcare costs and improve care.
Pricing: Patients pay a fee to have their condition reviewed online, receiving a list of potential diagnoses. Specific pricing not readily available on public searches, but implied to be a patient-paid service.
Included Health (formerly Grand Rounds Health and Doctor On Demand)FundedVisit
Included Health delivers integrated virtual care and navigation, offering personalized all-in-one healthcare including expert medical opinions and care coordination.
Pricing: Primarily offered through employers and health plans. Specific pricing for individuals not publicly available.
Best Doctors, Inc. (now part of Teladoc Health)FundedVisit
Best Doctors provides expert medical opinions and diagnostic accuracy by connecting members with top doctors in various specialties.
Pricing: Information not publicly available; services often integrated into insurance plans or employer benefits.
Medscape ConsultVisit
A free, physician-to-physician virtual consultation forum where doctors can seek diagnostic and therapeutic input from peers.
Pricing: Free for physicians.
Docus.aiVisit
Docus.ai pairs an AI health assistant with expert validation for symptom checks and record-based insights, also highlighting clinician-backed second opinions.
Pricing: Not publicly available from search results.
Cedars-Sinai Virtual Second OpinionVisit
Offers convenient, fast, at-home virtual second opinions from Cedars-Sinai specialists on treatment options for hundreds of conditions.
Pricing: Not publicly available, but states that most participants receive their full written report within five days.
Memorial Sloan Kettering Cancer Center (MSK) Second OpinionsVisit
MSK provides second opinions for people who have cancer or suspect they might, offering expert guidance and potentially different treatment recommendations.
Pricing: Not publicly available, but offers assistance in finding the right specialist and care advisors.

Funded players

What they charge

The pricing for medical second opinions varies. Online second opinion programs from academic medical centers averaged around $643 USD (ranging from $100-$850) as of October 2020. General second opinion consultations averaged $493 (ranging from $90-$1,300). Some services are integrated into employer health plans or insurance, making direct patient-paid pricing less transparent. Many crowdsourcing platforms require patients to pay a fee, but specific numbers are often not publicly disclosed for competitive reasons.

Crowdsourced medical diagnosis and second opinions

Preventive and restorative tooth care alternatives to root canal

Fertility tracking and ovulation prediction through accessible testing

Asynchronous telemedicine for chronic dermatology conditions